{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:10:57Z","timestamp":1790745057445,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Investigator Initiated Research of Domp\u00e9 farmaceutici S.p.A","award":["2021-1211"],"award-info":[{"award-number":["2021-1211"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40123-023-00857-z","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T18:03:15Z","timestamp":1701885795000},"page":"469-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A New Treatment for Recalcitrant Neurotrophic Keratopathy of Ocular Graft-Versus-Host Disease with Virus Infection"],"prefix":"10.1007","volume":"13","author":[{"given":"Yi","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-2073","authenticated-orcid":false,"given":"Jing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"1","key":"857_CR1","doi-asserted-by":"publisher","first-page":"Np15","DOI":"10.1177\/1120672120953343","volume":"32","author":"A Di Zazzo","year":"2022","unstructured":"Di Zazzo A, Varacalli G, Mori T, Coassin M. Long-term restoration of corneal sensitivity in neurotrophic keratopathy after rhNGF treatment. Eur J Ophthalmol. 2022;32(1):Np15-np18.","journal-title":"Eur J Ophthalmol"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","volume":"66","author":"HS Dua","year":"2018","unstructured":"Dua HS, Said DG, Messmer EM, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107\u201331.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"857_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40265-020-01289-w","volume":"80","author":"ED Deeks","year":"2020","unstructured":"Deeks ED, Lamb YN. Cenegermin: a review in neurotrophic keratitis. Drugs. 2020;80(5):489\u201394.","journal-title":"Drugs"},{"issue":"1","key":"857_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","volume":"127","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Massaro-Giordano M, Perez VL, et al. Topical recombinant human nerve growth factor (cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial. Ophthalmology. 2020;127(1):14\u201326.","journal-title":"Ophthalmology"},{"issue":"7","key":"857_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","volume":"257","author":"G Giannaccare","year":"2019","unstructured":"Giannaccare G, Pellegrini M, Bernabei F, Scorcia V, Campos E. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1341\u201351.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"857_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/OPX.0000000000001071","volume":"94","author":"SZ Munir","year":"2017","unstructured":"Munir SZ, Aylward J. A review of ocular graft-versus-host disease. Optom Vis Sci. 2017;94(5):545\u201355.","journal-title":"Optom Vis Sci"},{"issue":"12","key":"857_CR7","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00417-017-3759-x","volume":"255","author":"TC Tepelus","year":"2017","unstructured":"Tepelus TC, Chiu GB, Maram J, et al. Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol. 2017;255(12):2389\u201397.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajo.2020.04.036","volume":"217","author":"L Mastropasqua","year":"2020","unstructured":"Mastropasqua L, Lanzini M, Dua HS, et al. In vivo evaluation of corneal nerves and epithelial healing after treatment with recombinant nerve growth factor for neurotrophic keratopathy. Am J Ophthalmol. 2020;217:278\u201386.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"857_CR9","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1002\/jcp.27345","volume":"234","author":"L Mastropasqua","year":"2019","unstructured":"Mastropasqua L, Nubile M, Lanzini M, Calienno R, Dua HS. In vivo microscopic and optical coherence tomography classification of neurotrophic keratopathy. J Cell Physiol. 2019;234(5):6108\u201315.","journal-title":"J Cell Physiol"},{"issue":"4","key":"857_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","volume":"23","author":"A Lambiase","year":"2012","unstructured":"Lambiase A, Sacchetti M, Bonini S. Nerve growth factor therapy for corneal disease. Curr Opin Ophthalmol. 2012;23(4):296\u2013302.","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"857_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/aos.13844","volume":"97","author":"M Labetoulle","year":"2019","unstructured":"Labetoulle M, Baudouin C, Calonge M, et al. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019;97(2):137\u201345.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"857_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/OPX.0000000000001158","volume":"95","author":"Y Pan","year":"2018","unstructured":"Pan Y, Liu F, Qi X, Hu Y, Xu F, Jia H. Nerve growth factor changes and corneal nerve repair after keratoplasty. Optom Vis Sci. 2018;95(1):27\u201331.","journal-title":"Optom Vis Sci"},{"issue":"2","key":"857_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40135-015-0073-9","volume":"3","author":"C Belmonte","year":"2015","unstructured":"Belmonte C, Acosta MC, Merayo-Lloves J, Gallar J. What causes eye pain? Curr Ophthalmol Rep. 2015;3(2):111\u201321.","journal-title":"Curr Ophthalmol Rep"},{"issue":"5","key":"857_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","volume":"69","author":"S Nair","year":"2021","unstructured":"Nair S, Vanathi M, Mukhija R, Tandon R, Jain S, Ogawa Y. Update on ocular graft-versus-host disease. Indian J Ophthalmol. 2021;69(5):1038\u201350.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"857_CR15","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.3390\/ijms22116114","volume":"22","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Kawakami Y, Tsubota K. Cascade of inflammatory, fibrotic processes, and stress-induced senescence in chronic GVHD-related dry eye disease. Int J Mol Sci. 2021;22(11):6114.","journal-title":"Int J Mol Sci"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jtos.2020.11.003","volume":"19","author":"T Trinh","year":"2021","unstructured":"Trinh T, Santaella G, Mimouni M, et al. Assessment of response to multimodal management of neurotrophic corneal disease. Ocul Surf. 2021;19:330\u20135.","journal-title":"Ocul Surf"},{"issue":"11","key":"857_CR17","volume":"12","author":"AS Ahuja","year":"2020","unstructured":"Ahuja AS, Bowden FW 3rd, Robben JL. A novel treatment for neurotrophic corneal ulcer using topical cenegermin (OXERVATE\u2122) containing recombinant human nerve growth factor. Cureus. 2020;12(11):e11724.","journal-title":"Cureus"},{"issue":"1","key":"857_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-022-02237-5","volume":"17","author":"E Pedrotti","year":"2022","unstructured":"Pedrotti E, Bonacci E, Chierego C, et al. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy. Orphanet J Rare Dis. 2022;17(1):63.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00857-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:10:08Z","timestamp":1705158608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00857-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00857-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Peking University Third Hospital Medical Science Research Ethics Committee (IRB00006761-M2021101) and was conducted in compliance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}